Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum

M. Alvarez Figueroa, E. Dolgova, M. Gordukova, D. Belov (Moscow, Russian Federation)

Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis

Session: Microbiological advances in the diagnosis of tuberculosis
Session type: Poster Discussion
Number: 1416

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Alvarez Figueroa, E. Dolgova, M. Gordukova, D. Belov (Moscow, Russian Federation). Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum. Eur Respir J 2012; 40: Suppl. 56, 1416

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST. Source: International Congress 2017 – MDRTB: detection and management Year: 2017
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Comparison of molecular and immunological methods for a rapid diagnosis of smear-negative tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods Source: Eur Respir J, 51 (5) 1702189; 10.1183/13993003.02189-2017 Year: 2018
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
Novel sequence-based assay for detection of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens from patients with pulmonary tuberculosis in Russia Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB Source: Eur Respir J, 57 (1) 2001796; 10.1183/13993003.01796-2020 Year: 2021
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4) 1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008
Comparison of rapid in-house methods for drug susceptibility testing of mycobacterium tuberculosis with gold standards Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Colorimetric assays for rapid drug susceptibility testing of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003
FluoroType MTB system for the detection of pulmonary tuberculosis Source: ERJ Open Res, 3 (2) 00113-2016; 10.1183/23120541.00113-2016 Year: 2017